ROBOtic Care Outcomes Project:急性胆囊病变的机器人胆囊切除术结局
该研究基于美国医院去标识电子健康记录数据库(Intuitive Custom Hospital Analytics),纳入2020至2022年因急性胆囊疾病接受急诊腹腔镜(26,786例)或机器人(3,151例)胆囊切除术的患者,采用逆概率治疗加权(IPTW)的多因素logistic回归比较结局。结果显示,机器人组中转开腹的比值降低(OR 0.68;95%CI 0.49-0.93;p=0.035),但次全胆囊切除术的比值升高(OR 1.64;95%CI 1.03-2.60;p=0.037);手术部位感染、再入院、住院时间、医院获得性状况、胆管损伤或漏、院内死亡及住院费用两组相似。作者认为机器人胆囊切除术中转开腹更少、并发症相当,但次全胆囊切除更多,需进一步评估这些差异的长期影响。
要点
- 急性胆囊疾病急诊手术中,机器人组较腹腔镜组中转开腹的比值降低:OR 0.68(95%CI 0.49-0.93;p=0.035)。
- 机器人组次全胆囊切除术的比值升高:OR 1.64(95%CI 1.03-2.60;p=0.037)。
- 手术部位感染、再入院、住院时间、医院获得性状况、胆管损伤或漏、院内死亡两组相似。
- 住院费用两组无显著差异。
- 作者认为需进一步评估中转开腹减少与次全胆囊切除增加这些差异的长期影响。
适用人群与场景
- 2020至2022年因急性胆囊疾病接受急诊腹腔镜或机器人胆囊切除术的患者,数据来自美国医院去标识电子健康记录提取。
- 纳入腹腔镜26,786例、机器人3,151例;64%为女性,60%≥45岁,24%肥胖。
- 约5.5%患者合并胰腺炎,4%合并脓毒症,4%合并胆道梗阻。
诊断标准与关键阈值
- 中转开腹或次全胆囊切除术及并发症采用ICD10和/或CPT编码定义。
研究设计与关键结果
- 研究类型:基于大型真实世界数据库的比较研究;腹腔镜26,786例 vs 机器人3,151例。
- 主要终点:IPTW后机器人组中转开腹的比值降低(OR 0.68;95%CI 0.49-0.93;p=0.035),次全胆囊切除术的比值升高(OR 1.64;95%CI 1.03-2.60;p=0.037)。
- 手术部位感染、再入院、住院时间、医院获得性状况、胆管损伤或漏、院内死亡两组相似;住院费用无显著差异。
- 作者结论:机器人胆囊切除术中转开腹更少、并发症相当,但次全胆囊切除更多,需进一步评估长期影响。
证据类型、等级与局限
- 证据类型:治疗/管理类研究,证据等级Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,对急性胆囊疾病行急诊胆囊切除术时,机器人途径与腹腔镜途径相比中转开腹的比值更低、并发症相当,但次全胆囊切除术的比值更高;需进一步评估这些差异的长期影响。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Robotic cholecystectomy is being increasingly used for patients with acute gallbladder disease who present to the emergency department, but clinical evidence is limited. We aimed to compare the outcomes of emergent laparoscopic and robotic cholecystectomies in a large real-world database.
METHODS: Patients who received emergent laparoscopic or robotic cholecystectomies from 2020 to 2022 were identified from the Intuitive Custom Hospital Analytics database, based on deidentified extraction of electronic health record data from US hospitals. Conversion to open or subtotal cholecystectomy and complications were defined using ICD10 and/or CPT codes. Multivariate logistic regression with inverse probability treatment weighting (IPTW) was performed to compare clinical outcomes of laparoscopic versus robotic approach after balancing covariates. Cost analysis was performed with activity-based costing and adjustment for inflation.
RESULTS: Of 26,786 laparoscopic and 3,151 robotic emergent cholecystectomy patients being included, 64% were female, 60% were ≥45 years, and 24% were obese. Approximately 5.5% patients presented with pancreatitis, and 4% each presenting with sepsis and biliary obstruction. After IPTW, distributions of all baseline covariates were balanced. Robotic cholecystectomy decreased odds of conversion to open (odds ratio, 0.68; 95% confidence interval, 0.49-0.93; p = 0.035), but increased odds of subtotal cholecystectomy (odds ratio, 1.64; 95% confidence interval, 1.03-2.60; p = 0.037). Surgical site infection, readmission, length of stay, hospital acquired conditions, bile duct injury or leak, and hospital mortality were similar in both groups. There was no significant difference in hospital cost.
CONCLUSION: Robotic cholecystectomy has reduced odds of conversion to open and comparable complications, but increased odds of subtotal cholecystectomy compared with laparoscopic cholecystectomy for acute gallbladder diseases. Further work is required to assess the long-term implications of these differences.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level IV.
参考来源
- Greenberg S, Abou Assali M, Li Y, et al. ROBOtic Care Outcomes Project for acute gallbladder pathology. J Trauma Acute Care Surg. 2024. PMID: 38189678. doi:10.1097/TA.0000000000004240
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。